Study on dosage of cypofol in painless gastroscopic sedation of obese patients
Conditions
Interventions
Group 18-65 years old:The dose of cypofol is increased or decreased according to the patient s response to loss of consciousness
Sponsors
Hangzhou Red Cross Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Patients intending to undergo painless gastroscopy;(2) AmericanSociety of Anesthesiologists (ASA) grade II;(3) Age 18-65 years old;(4) BMI30-35kg/m2.
Exclusion criteria
Exclusion criteria: (1) Have a history of allergy to the drugs involved in the study;(2) A history of upper respiratory tract infection within two weeks;(3) Asthma attacks, uncontrolled hypertension, diabetes, hyperthyroidism or hypothyroidism;(4) mental system diseases (such as schizophrenia, depression, etc.), epilepsy history and cognitive dysfunction;(5) Have a history of psychotropic drug and narcotic drug abuse;(6) Abnormal liver function, renal function and coagulation function;(7) Pregnant or lactating women;(8) RR 24 times/min in screening period or baseline period, SpO2 < 95% when breathing air
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Loss of consciousness; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse reactions during surgery; | — |
Countries
China
Contacts
Public ContactJie Zhao
Hangzhou Red Cross Hospital
Outcome results
None listed